益生菌对糖尿病前期患者VEGF、脂联素和糖脂代谢的影响:一项随机、双盲、安慰剂对照的临床试验

IF 3.5 2区 农林科学 Q2 FOOD SCIENCE & TECHNOLOGY
Mehrdad Sarabi, Ashkan Torshizian, Zahra Mazloum Khorasani, Abdollah Firoozi, Hassan Mehrad Majd, Nastaran Khoshhal, Nikoo Saeidi, Mina AkbariRad
{"title":"益生菌对糖尿病前期患者VEGF、脂联素和糖脂代谢的影响:一项随机、双盲、安慰剂对照的临床试验","authors":"Mehrdad Sarabi,&nbsp;Ashkan Torshizian,&nbsp;Zahra Mazloum Khorasani,&nbsp;Abdollah Firoozi,&nbsp;Hassan Mehrad Majd,&nbsp;Nastaran Khoshhal,&nbsp;Nikoo Saeidi,&nbsp;Mina AkbariRad","doi":"10.1002/fsn3.70146","DOIUrl":null,"url":null,"abstract":"<p>It is debated that probiotics can improve glycolipid metabolism and slow the progression of prediabetes to diabetes mellitus. This study aimed to evaluate the effect of probiotics on lipid profile, glucose homeostasis, serum level of resistin, adiponectin, and vascular endothelial growth factor (VEGF) in prediabetic patients. This double-blind, randomized, placebo-controlled clinical trial was conducted on prediabetic patients in the Endocrinology clinic of Ghaem Hospital. Patients were randomly divided into two groups: the probiotics group was prescribed a daily 500-mg capsule of probiotics (10<sup>9</sup> colony-forming units), while the other received a placebo capsule with the same appearance. After 3 months, the effect of probiotic administration on laboratory parameters indicative of glycolipid metabolism, resistin, adiponectin, VEGF, body mass index (BMI), and blood pressure was compared between groups. This study was registered in the Iranian Registry of Clinical Trials (IRCT 20190801044405 N2). Fifty-two patients were included in the final analysis, with 26 patients in each group. The mean age of patients was 43.75 ± 8.45. At the beginning, both groups were similar in all demographic characteristics and measured serum levels of investigated biomarkers (<i>p</i> &gt; 0.05 for all parameters). Both groups exhibited significant changes in BMI and fasting blood sugar (FBS). However, regarding FBS, the magnitude of change was significantly greater in patients treated with probiotics (<i>p</i> = 0.022). Our findings also revealed a significant increase in HDL (<i>p</i> = 0.001), adiponectin (<i>p</i> &lt; 0.001), and VEGF (<i>p</i> = 0.024) serum levels and a significant decrease in HbA1c (<i>p</i> = 0.034), LDL (<i>p</i> = 0.002), TG (<i>p</i> &lt; 0.001), and total cholesterol (<i>p</i> = 0.001) exclusively in the probiotics group. Probiotic supplementation efficiently improved glycolipid metabolism, adiponectin, and VEGF serum levels.</p>","PeriodicalId":12418,"journal":{"name":"Food Science & Nutrition","volume":"13 5","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/fsn3.70146","citationCount":"0","resultStr":"{\"title\":\"Impact of Probiotics Administration on the VEGF, Adiponectin, and Glycolipid Metabolism, in Prediabetic Patients: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial\",\"authors\":\"Mehrdad Sarabi,&nbsp;Ashkan Torshizian,&nbsp;Zahra Mazloum Khorasani,&nbsp;Abdollah Firoozi,&nbsp;Hassan Mehrad Majd,&nbsp;Nastaran Khoshhal,&nbsp;Nikoo Saeidi,&nbsp;Mina AkbariRad\",\"doi\":\"10.1002/fsn3.70146\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>It is debated that probiotics can improve glycolipid metabolism and slow the progression of prediabetes to diabetes mellitus. This study aimed to evaluate the effect of probiotics on lipid profile, glucose homeostasis, serum level of resistin, adiponectin, and vascular endothelial growth factor (VEGF) in prediabetic patients. This double-blind, randomized, placebo-controlled clinical trial was conducted on prediabetic patients in the Endocrinology clinic of Ghaem Hospital. Patients were randomly divided into two groups: the probiotics group was prescribed a daily 500-mg capsule of probiotics (10<sup>9</sup> colony-forming units), while the other received a placebo capsule with the same appearance. After 3 months, the effect of probiotic administration on laboratory parameters indicative of glycolipid metabolism, resistin, adiponectin, VEGF, body mass index (BMI), and blood pressure was compared between groups. This study was registered in the Iranian Registry of Clinical Trials (IRCT 20190801044405 N2). Fifty-two patients were included in the final analysis, with 26 patients in each group. The mean age of patients was 43.75 ± 8.45. At the beginning, both groups were similar in all demographic characteristics and measured serum levels of investigated biomarkers (<i>p</i> &gt; 0.05 for all parameters). Both groups exhibited significant changes in BMI and fasting blood sugar (FBS). However, regarding FBS, the magnitude of change was significantly greater in patients treated with probiotics (<i>p</i> = 0.022). Our findings also revealed a significant increase in HDL (<i>p</i> = 0.001), adiponectin (<i>p</i> &lt; 0.001), and VEGF (<i>p</i> = 0.024) serum levels and a significant decrease in HbA1c (<i>p</i> = 0.034), LDL (<i>p</i> = 0.002), TG (<i>p</i> &lt; 0.001), and total cholesterol (<i>p</i> = 0.001) exclusively in the probiotics group. Probiotic supplementation efficiently improved glycolipid metabolism, adiponectin, and VEGF serum levels.</p>\",\"PeriodicalId\":12418,\"journal\":{\"name\":\"Food Science & Nutrition\",\"volume\":\"13 5\",\"pages\":\"\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/fsn3.70146\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Food Science & Nutrition\",\"FirstCategoryId\":\"97\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/fsn3.70146\",\"RegionNum\":2,\"RegionCategory\":\"农林科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"FOOD SCIENCE & TECHNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Food Science & Nutrition","FirstCategoryId":"97","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/fsn3.70146","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"FOOD SCIENCE & TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

益生菌可以改善糖脂代谢,减缓糖尿病前期向糖尿病的进展,这一点一直存在争议。本研究旨在评估益生菌对糖尿病前期患者血脂、葡萄糖稳态、血清抵抗素、脂联素和血管内皮生长因子(VEGF)水平的影响。这项双盲、随机、安慰剂对照的临床试验是在Ghaem医院内分泌科门诊对糖尿病前期患者进行的。患者被随机分为两组:益生菌组每天服用500毫克益生菌胶囊(109个菌落形成单位),而另一组服用外观相同的安慰剂胶囊。3个月后,比较益生菌给药对各组糖脂代谢、抵抗素、脂联素、VEGF、体重指数(BMI)和血压等实验室指标的影响。本研究已在伊朗临床试验注册中心注册(IRCT 20190801044405 N2)。52例患者纳入最终分析,每组26例。患者平均年龄43.75±8.45岁。开始时,两组在所有人口统计学特征和所调查生物标志物的血清测量水平上相似(所有参数p >; 0.05)。两组的BMI和空腹血糖(FBS)均有显著变化。然而,对于FBS,使用益生菌治疗的患者的变化幅度明显更大(p = 0.022)。我们的研究结果还显示,在益生菌组中,HDL (p = 0.001)、脂联素(p < 0.001)和VEGF (p = 0.024)血清水平显著升高,HbA1c (p = 0.034)、LDL (p = 0.002)、TG (p < 0.001)和总胆固醇(p = 0.001)显著降低。补充益生菌可有效改善糖脂代谢、脂联素和VEGF血清水平。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Impact of Probiotics Administration on the VEGF, Adiponectin, and Glycolipid Metabolism, in Prediabetic Patients: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial

Impact of Probiotics Administration on the VEGF, Adiponectin, and Glycolipid Metabolism, in Prediabetic Patients: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial

It is debated that probiotics can improve glycolipid metabolism and slow the progression of prediabetes to diabetes mellitus. This study aimed to evaluate the effect of probiotics on lipid profile, glucose homeostasis, serum level of resistin, adiponectin, and vascular endothelial growth factor (VEGF) in prediabetic patients. This double-blind, randomized, placebo-controlled clinical trial was conducted on prediabetic patients in the Endocrinology clinic of Ghaem Hospital. Patients were randomly divided into two groups: the probiotics group was prescribed a daily 500-mg capsule of probiotics (109 colony-forming units), while the other received a placebo capsule with the same appearance. After 3 months, the effect of probiotic administration on laboratory parameters indicative of glycolipid metabolism, resistin, adiponectin, VEGF, body mass index (BMI), and blood pressure was compared between groups. This study was registered in the Iranian Registry of Clinical Trials (IRCT 20190801044405 N2). Fifty-two patients were included in the final analysis, with 26 patients in each group. The mean age of patients was 43.75 ± 8.45. At the beginning, both groups were similar in all demographic characteristics and measured serum levels of investigated biomarkers (p > 0.05 for all parameters). Both groups exhibited significant changes in BMI and fasting blood sugar (FBS). However, regarding FBS, the magnitude of change was significantly greater in patients treated with probiotics (p = 0.022). Our findings also revealed a significant increase in HDL (p = 0.001), adiponectin (p < 0.001), and VEGF (p = 0.024) serum levels and a significant decrease in HbA1c (p = 0.034), LDL (p = 0.002), TG (p < 0.001), and total cholesterol (p = 0.001) exclusively in the probiotics group. Probiotic supplementation efficiently improved glycolipid metabolism, adiponectin, and VEGF serum levels.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Food Science & Nutrition
Food Science & Nutrition Agricultural and Biological Sciences-Food Science
CiteScore
7.40
自引率
5.10%
发文量
434
审稿时长
24 weeks
期刊介绍: Food Science & Nutrition is the peer-reviewed journal for rapid dissemination of research in all areas of food science and nutrition. The Journal will consider submissions of quality papers describing the results of fundamental and applied research related to all aspects of human food and nutrition, as well as interdisciplinary research that spans these two fields.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信